The impact of antiviral therapy on hepatocellular carcinoma epidemiology
The development of nucleos(t)ide analogs and direct antiviral agents has revolutionized the management of chronic infection with HBV and HCV, respectively. These regimens allow to expand treatment to virtually all infected, including those with poor hepatic reserve and those with severe comorbiditie...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2018-01-01
|
| סדרה: | Hepatic Oncology |
| נושאים: | |
| גישה מקוונת: | https://www.futuremedicine.com/doi/10.2217/hep-2017-0024 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|